194 related articles for article (PubMed ID: 32319602)
21. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
22. Interferons command Trim22 to fight against viruses.
Lian Q; Sun B
Cell Mol Immunol; 2017 Sep; 14(9):794-796. PubMed ID: 28782753
[No Abstract] [Full Text] [Related]
23. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
24. Control of FoxO4 Activity and Cell Survival by TRIM22 Directs TLR3-Stimulated Cells Toward IFN Type I Gene Induction or Apoptosis.
Oteiza A; Mechti N
J Interferon Cytokine Res; 2015 Nov; 35(11):859-74. PubMed ID: 26237181
[TBL] [Abstract][Full Text] [Related]
25. SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway.
Li X; Li G; Li L; Gao B; Niu X; Wang Y; Wang Z
Brain Behav; 2024 Mar; 14(3):e3465. PubMed ID: 38468469
[TBL] [Abstract][Full Text] [Related]
26. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
27. Identification of TRIM22 as a progesterone-responsive gene in Ishikawa endometrial cancer cells.
Saito-Kanatani M; Urano T; Hiroi H; Momoeda M; Ito M; Fujii T; Inoue S
J Steroid Biochem Mol Biol; 2015 Nov; 154():217-25. PubMed ID: 26316153
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
29. A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1.
Gao B; Wang Y; Xu W; Duan Z; Xiong S
J Immunol; 2010 Aug; 185(4):2314-23. PubMed ID: 20631312
[TBL] [Abstract][Full Text] [Related]
30. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
31. TRIM22. A Multitasking Antiviral Factor.
Pagani I; Poli G; Vicenzi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440633
[TBL] [Abstract][Full Text] [Related]
32. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
33. Identification of TRIM22 as a RING finger E3 ubiquitin ligase.
Duan Z; Gao B; Xu W; Xiong S
Biochem Biophys Res Commun; 2008 Sep; 374(3):502-6. PubMed ID: 18656448
[TBL] [Abstract][Full Text] [Related]
34. TRIM22 inhibits respiratory syncytial virus replication by targeting JAK-STAT1/2 signaling.
Wang Y; Chen Y; Lin Y; Quan Y; Xiao X; Zhang R
J Med Virol; 2021 Jun; 93(6):3412-3419. PubMed ID: 32803897
[TBL] [Abstract][Full Text] [Related]
35. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies.
Sivaramakrishnan G; Sun Y; Tan SK; Lin VC
Exp Cell Res; 2009 May; 315(8):1521-32. PubMed ID: 19331816
[TBL] [Abstract][Full Text] [Related]
36. p300, but not PCAF, collaborates with IRF-1 in stimulating TRIM22 expression independently of its histone acetyltransferase activity.
Gao B; Xu W; Zhong L; Zhang Q; Su Y; Xiong S
Eur J Immunol; 2013 Aug; 43(8):2174-84. PubMed ID: 23670564
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional up-regulation of Sox9 by NF-κB in endometrial carcinoma cells, modulating cell proliferation through alteration in the p14(ARF)/p53/p21(WAF1) pathway.
Saegusa M; Hashimura M; Suzuki E; Yoshida T; Kuwata T
Am J Pathol; 2012 Aug; 181(2):684-92. PubMed ID: 22698986
[TBL] [Abstract][Full Text] [Related]
38. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
39. Tripartite Motif-Containing 46 Promotes Viability and Inhibits Apoptosis of Osteosarcoma Cells by Activating NF-B Signaling Through Ubiquitination of PPAR.
Jiang W; Cai X; Xu T; Liu K; Yang D; Fan L; Li G; Yu X
Oncol Res; 2020 Sep; 28(4):409-421. PubMed ID: 32295675
[TBL] [Abstract][Full Text] [Related]
40. Identification of TRIM22 single nucleotide polymorphisms associated with loss of inhibition of HIV-1 transcription and advanced HIV-1 disease.
Ghezzi S; Galli L; Kajaste-Rudnitski A; Turrini F; Marelli S; Toniolo D; Casoli C; Riva A; Poli G; Castagna A; Vicenzi E
AIDS; 2013 Sep; 27(15):2335-44. PubMed ID: 23921607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
